Indication
Granulosa Cell Tumor
1 clinical trial
1 product
Clinical trial
A Phase 2 Trial of Nirogacestat in Patients With Recurrent Ovarian Granulosa Cell TumorsStatus: Active (not recruiting), Estimated PCD: 2026-07-01
Product
Nirogacestat1 clinical trial
1 product